RedHill Biopharma Ltd. SEC filings RDHL
RedHill Biopharma Ltd. has 1,000 filings in SEC EDGAR's recent list, going back to Mar 6, 2013. Its latest annual report, Form 20-F, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 13, 2026 | — |
| 424B3 | Prospectus | Jul 14, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 2, 2026 | — |
| 424B5 | Prospectus supplement | Jun 29, 2026 | — |
| 424B5 | Prospectus supplement | May 7, 2026 | — |
| POS AM | Filing | May 4, 2026 | — |
| 424B3 | Prospectus | Feb 2, 2026 | — |
| S-8 | Employee stock plan registration | Jan 22, 2026 | — |
| F-1/A | Filing | Jan 22, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Dec 31, 2025 | — |
| 424B5 | Prospectus supplement | Nov 26, 2025 | — |
| 424B3 | Prospectus | Oct 21, 2025 | — |
| POS AM | Filing | Sep 5, 2025 | — |
| POS AM | Filing | Sep 5, 2025 | — |
| 424B3 | Prospectus | Jul 2, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Jun 25, 2025 | — |
| S-8 | Employee stock plan registration | Mar 25, 2025 | — |
| 424B5 | Prospectus supplement | Feb 3, 2025 | — |
| 424B3 | Prospectus | Aug 13, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 9, 2024 | — |
| 424B3 | Prospectus | Aug 7, 2024 | — |
| S-8 | Employee stock plan registration | Jun 20, 2024 | — |
| POS AM | Filing | Apr 18, 2024 | — |
| 424B5 | Prospectus supplement | Apr 2, 2024 | — |
| 424B3 | Prospectus | Feb 16, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Feb 9, 2024 | — |
| 424B5 | Prospectus supplement | Jan 26, 2024 | — |
| 424B3 | Prospectus | Oct 26, 2023 | — |
| F-3/A | Filing | Oct 23, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 13, 2023 | — |
| 424B3 | Prospectus | Aug 11, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 4, 2023 | — |
| 424B3 | Prospectus | Jul 25, 2023 | — |
| 424B3 | Prospectus | Jul 25, 2023 | — |
| 424B5 | Prospectus supplement | Jul 25, 2023 | — |
| S-8 | Employee stock plan registration | Jun 29, 2023 | — |
| 424B5 | Prospectus supplement | Apr 3, 2023 | — |
| 424B3 | Prospectus | Mar 22, 2023 | — |
| F-6EF | Form f-6ef | Dec 8, 2022 | — |
| 424B5 | Prospectus supplement | Dec 6, 2022 | — |
| 424B5 | Prospectus supplement | Dec 2, 2022 | — |
| 424B3 | Prospectus | Nov 10, 2022 | — |
| S-8 | Employee stock plan registration | Jun 27, 2022 | — |
| 424B5 | Prospectus supplement | May 11, 2022 | — |
| S-8 | Employee stock plan registration | Jan 11, 2022 | — |
| 424B5 | Prospectus supplement | Nov 22, 2021 | — |
| 424B5 | Prospectus supplement | Nov 18, 2021 | — |
| 424B3 | Prospectus | Aug 9, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 29, 2021 | — |
| S-8 | Employee stock plan registration | May 3, 2021 | — |
| 424B3 | Prospectus | Apr 8, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 30, 2021 | — |
| S-8 | Employee stock plan registration | Mar 25, 2021 | — |
| 424B5 | Prospectus supplement | Mar 3, 2021 | — |
| FWP | Free writing prospectus | Mar 2, 2021 | — |
| FWP | Free writing prospectus | Mar 1, 2021 | — |
| FWP | Free writing prospectus | Mar 1, 2021 | — |
| 424B5 | Prospectus supplement | Mar 1, 2021 | — |
| 424B5 | Prospectus supplement | Jan 13, 2021 | — |
| FWP | Free writing prospectus | Jan 12, 2021 | — |
| FWP | Free writing prospectus | Jan 11, 2021 | — |
| FWP | Free writing prospectus | Jan 11, 2021 | — |
| 424B5 | Prospectus supplement | Jan 11, 2021 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 24, 2019 | — |
| S-8 | Employee stock plan registration | Jul 24, 2019 | — |
| 424B5 | Prospectus supplement | Jul 23, 2019 | — |
| 424B5 | Prospectus supplement | Dec 10, 2018 | — |
| 424B5 | Prospectus supplement | Dec 4, 2018 | — |
| 424B5 | Prospectus supplement | Aug 10, 2018 | — |
| 424B5 | Prospectus supplement | Aug 9, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | Jul 23, 2018 | — |
| S-8 | Employee stock plan registration | May 23, 2018 | — |
| 424B5 | Prospectus supplement | Nov 9, 2017 | — |
| 424B5 | Prospectus supplement | Nov 7, 2017 | — |
| S-8 | Employee stock plan registration | Jul 25, 2017 | — |
| 424B5 | Prospectus supplement | Dec 23, 2016 | — |
| 424B5 | Prospectus supplement | Dec 23, 2016 | — |
| 424B5 | Prospectus supplement | Dec 21, 2016 | — |
| 424B5 | Prospectus supplement | Dec 21, 2016 | — |
| FWP | Free writing prospectus | Nov 1, 2016 | — |
| FWP | Free writing prospectus | Nov 1, 2016 | — |
| 424B5 | Prospectus supplement | Nov 1, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 25, 2016 | — |
| S-8 | Employee stock plan registration | Oct 29, 2015 | — |
| 424B5 | Prospectus supplement | Jul 17, 2015 | — |
| FWP | Free writing prospectus | Jul 15, 2015 | — |
| FWP | Free writing prospectus | Jul 15, 2015 | — |
| 424B5 | Prospectus supplement | Jul 14, 2015 | — |
| 424B5 | Prospectus supplement | Feb 10, 2015 | — |
| 424B5 | Prospectus supplement | Feb 9, 2015 | — |
| 424B3 | Prospectus | Feb 4, 2014 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 23, 2014 | — |
| S-8 | Employee stock plan registration | May 2, 2013 | — |
Showing 93 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RDHL (Nasdaq)
- Incorporated in
- Israel
- Headquarters
- Tel Aviv, Israel
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1553846
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.